Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies

被引：171

作者：

Calabrese, L. H.

Zein, N. N.

Vassilopoulos, D.

机构：

[1] Cleveland Clin Fdn, Dept Rheumat & Immunol Dis, Cleveland, OH 44195 USA

[2] Cleveland Clin Fdn, Dept Gastroenterol, Cleveland, OH 44195 USA

[3] Univ Athens, Sch Med, Hippokratio Gen Hosp, GR-11527 Athens, Greece

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷 / 08期

关键词：

D O I：

10.1136/ard.2005.043257

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Understanding of the natural history and basic biology of hepatitis B virus ( HBV) has increased greatly in recent years. In view of this, the following are reviewed here: ( a) recent advances in HBV biology pertinent to the rheumatic disease population; ( b) the risks of HBV reactivation in patients with rheumatic disease undergoing immunosuppression; and ( c) potential strategies to manage these risks.

引用

收藏

页码：983 / 989

页数：7

相关论文

共 55 条

[1] Prevention of hepatitis B flare-up during chemotherapy using lamivudine:: case report and review of the literature [J].

Al-Taie, OH ;

Mörk, H ;

Gassel, AM ;

Wilhelm, M ;

Weissbrich, B ;

Scheurlen, M .

ANNALS OF HEMATOLOGY, 1999, 78 (05) :247-249

[2] Occult hepatitis B virus infection: implications in transfusion [J].

Allain, JP .

VOX SANGUINIS, 2004, 86 (02) :83-91

[3] HBV reactivation after kidney transplantation [J].

Berger, A ;

Preiser, W ;

Kachel, HG ;

Stürmer, M ;

Doerr, HW .

JOURNAL OF CLINICAL VIROLOGY, 2005, 32 (02) :162-165

[4] Immunomodulatory drugs in Crohn's disease patients with hepatitis B or C virus infection [J].

Biancone, L ;

Blanco, GD ;

Pallone, F ;

Castiglione, F ;

Bresci, G ;

Sturniolo, G .

GASTROENTEROLOGY, 2002, 122 (02) :593-594

[5]

BIRD GLA, 1989, Q J MED, V73, P895

[6] Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection [J].

Calabrese, LH ;

Zein, N ;

Vassilopoulos, D .

ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 :18-24

[7] Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients [J].

Chan, TM ;

Fang, GX ;

Tang, CSO ;

Cheng, IKP ;

Lai, KN ;

Ho, SKN .

HEPATOLOGY, 2002, 36 (05) :1246-1252

[8] Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma [J].

Cheng, AL ;

Hsiung, CA ;

Su, IJ ;

Chen, PJ ;

Chang, MC ;

Tsao, CJ ;

Kao, WY ;

Uen, WC ;

Hsu, CH ;

Tien, HF ;

Chao, TY ;

Chen, LT ;

Whang-Peng, J .

HEPATOLOGY, 2003, 37 (06) :1320-1328

[9]

CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333

[10] EASL International Concensus Conference on Hepatitis B -: 13-14 September, 2002 Geneva, Switzerland Consensus Statement (Long version) [J].

de Franchis, R ;

Hadengue, A ;

Lau, G ;

Lavanchy, D ;

Lok, A ;

McIntyre, N ;

Mele, A ;

Paumgartner, G ;

Pietrangelo, A ;

Rodés, J ;

Rosenberg, W ;

Valla, D .

JOURNAL OF HEPATOLOGY, 2003, 39 :S3-S25

← 1 2 3 4 5 6 →